Funding for this research was provided by:
National Institute of Health (GM120159, GM120159)
Article History
Received: 23 March 2024
Accepted: 20 April 2024
First Online: 18 May 2024
Compliance with ethical standards
:
: The authors declare the following competing financial interest(s): PW is an inventor on the patents and patent applications based on this work. The University of Alabama at Birmingham (UAB) has intellectual property rights to VSA adjuvants developed in PW’s laboratory. PW is a co-founder of Adjuvax LLC.